Olmutinib hydrochloride
Based on 12 publication(s) in Google Scholar
Olmutinib hydrochloride is an orally active and irreversible third EGFR tyrosine kinase inhibitor that binds to a cysteine residue near the kinase domain. Olmutinib hydrochloride is used for NSCLC.
For research use only. We do not sell to patients.
- CAS No.: 1842366-97-5
- Formula: C26H28Cl2N6O2S
- Molecular Weight:559.51
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Publications Citing Use of MedChemExpress (MCE) Olmutinib hydrochloride
More- Acta Pharm Sin B. 2018 Jul;8(4):563-574. [Abstract]
- J Pharm Anal. 2021 Dec;11(6):799-807. [Abstract]
- Mol Syst Biol. 2024 Jan;20(1):28-55. [Abstract]
- RSC Adv. 2018 Dec 4;8(70):40387-40394. [Abstract]
- Rheumatology (Oxford). 2025 Aug 13:keaf437. [Abstract]
- Biomedicines. 2024 Jan 7;12(1):123. [Abstract]
- J Sep Sci. 2020 Feb;43(4):708-718. [Abstract]
- J Biomol Struct Dyn. 2022;40(24):14236-14246. [Abstract]
- Biochem Biophys Res Commun. 2026 Feb 12:800:153165.
- Med Sci Monit. 2020 Aug 24;26:e924922. [Abstract]
- bioRxiv. 2026 May 8:2026.05.05.723030. [Abstract]
- Patent. US20220177473A1.
Customer Validation & Images
-
WB
All EGFR Isoforms
More
Biological Activity
Chemical Information
-
CAS No. 1842366-97-5
-
Molecular Weight 559.51
-
Formula C26H28Cl2N6O2S
-
SMILES
O=C(NC1=CC(OC2=NC(NC3=CC=C(N4CCN(CC4)C)C=C3)=NC5=C2SC=C5)=CC=C1)C=C.Cl.Cl
-
Synonyms
HM61713 hydrochloride; BI 1482694 hydrochloride
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (12)
-
Journal Impact Factor
-
Most Recent
-
Acta Pharm Sin B
Olmutinib (HM61713) reversed multidrug resistance by inhibiting the activity of ATP-binding cassette subfamily G member 2 in vitro and in vivo. [Abstract]2018 Jul;8(4):563-574. PMID: 30109181
Olmutinib hydrochloride purchased from MedChemExpress. Usage Cited in: Acta Pharm Sin B. 2018 Jul;8(4):563-574. [Abstract]
The protein levels of ABCG2 in MDR cells after different concentrations Olmutinib stimulation for 48 h are measured by Western blot analysis (GAPDH as loading control).
-
J Pharm Anal
Synergistic effects of methyl 2-cyano-3,11-dioxo-18beta-olean-1,-12-dien-30-oate and erlotinib on erlotinib-resistant non-small cell lung cancer cells. [Abstract]2021 Dec;11(6):799-807. PMID: 35028186 -
Mol Syst Biol
Illuminating phenotypic drug responses of sarcoma cells to kinase inhibitors by phosphoproteomics. [Abstract]2024 Jan;20(1):28-55. PMID: 38177929 -
RSC Adv
Investigation of the metabolic stability of olmutinib by validated LC-MS/MS: quantification in human plasma. [Abstract]2018 Dec 4;8(70):40387-40394. PMID: 35558213 -
Rheumatology (Oxford)
Autophagy inhibitors block pathogenic NET release in immune-mediated inflammatory disease without impairing host defence. [Abstract]2025 Aug 13:keaf437. PMID: 40802538 -
Biomedicines
Extracellular Vesicles and Exosomes: Novel Insights and Perspectives on Lung Cancer from Early Detection to Targeted Treatment. [Abstract]2024 Jan 7;12(1):123. PMID: 38255228 -
J Sep Sci
Detection and characterization of olmutinib reactive metabolites by LC-MS/MS: Elucidation of bioactivation pathways. [Abstract]2020 Feb;43(4):708-718. PMID: 31788977 -
J Biomol Struct Dyn
Spectroscopic, molecular docking and dynamic simulation studies of binding between the new anticancer agent olmutinib and human serum albumin. [Abstract]2022;40(24):14236-14246. PMID: 34766879 -
-
Med Sci Monit
2020 Aug 24;26:e924922. PMID: 32830792 -
bioRxiv
2026 May 8:2026.05.05.723030. PMID: 42146668 -
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Powered by Bioz